Celltrion Group has completed a neutralisation test and identified the antibody candidates that showed the most promise for neutralising the novel coronavirus, SARS-CoV-2, which causes Covid-19.
Earlier this month, the company partnered with the Korea Centers for Disease Control and Prevention (KCDC) to screen the initially discovered 300 different types of antibodies.
These antibodies are based on the blood of recovered patients in Korea, noted Celltrion. After screening the candidates on their ability to attach to the spike protein of the virus, the company detected a total of 38 potent neutralising antibodies.
Of the 38 antibodies, 14 are said to be powerful at neutralising SARS-CoV-2. The next steps for the candidates are cell-line